Autolus Therapeutics (AUTL) Deferred Taxes (2020 - 2025)
Autolus Therapeutics posted quarterly Deferred Taxes of $1.2 million for Q4 2025, up 929.79% year-on-year from $113615.7 in Q4 2024, and up 9100.0% on a QoQ basis from -$13000.0 in Q3 2025.
Autolus Therapeutics (AUTL) has 6 years of Deferred Taxes data on file, last reported at $1.2 million in Q4 2025.
- For the quarter ending Q4 2025, Deferred Taxes rose 929.79% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2025 stood at $286000.0 (up 54.59% YoY), and the FY2025 full-year result was $286000.0, up 54.59% from the prior year.
- Deferred Taxes for Q4 2025 stood at $1.2 million, up from -$13000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $1.2 million in Q4 2025 and bottomed at -$487000.0 in Q1 2025.
- The 5-year median for Deferred Taxes is $37000.0 (2023), against an average of $89850.0.
- Peak annual rise in Deferred Taxes reached 929.79% in 2025, while the deepest fall reached 418.92% in 2025.
- A 5-year view of Deferred Taxes shows it stood at -$276000.0 in 2021, then declined by 15.58% to -$319000.0 in 2022, then soared by 246.08% to $466000.0 in 2023, then tumbled by 130.26% to -$141000.0 in 2024, then jumped by 929.79% to $1.2 million in 2025.
- The last three Deferred Taxes figures came in at $1.2 million (Q4 2025), -$13000.0 (Q3 2025), and -$384000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -65.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 96.00 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 9.31 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | 1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | -13,000.00 |
| Jun 30, 2025 | -384,000.00 |
| Mar 31, 2025 | -487,000.00 |
| Dec 31, 2024 | -141,000.00 |
| Sep 30, 2024 | 168,000.00 |
| Jun 30, 2024 | -74,000.00 |
| Mar 31, 2024 | 232,000.00 |
| Dec 31, 2023 | 466,000.00 |
| Sep 30, 2023 | 238,000.00 |
| Jun 30, 2023 | 87,000.00 |
| Mar 31, 2023 | 195,000.00 |
| Dec 31, 2022 | -319,000.00 |
| Sep 30, 2022 | 1.01 Mn |
| Jun 30, 2022 | -253,000.00 |
| Mar 31, 2022 | -174,000.00 |
| Dec 31, 2021 | -276,000.00 |
| Sep 30, 2021 | 233,000.00 |
| Jun 30, 2021 | 395,000.00 |
| Mar 31, 2021 | -280,000.00 |
| Dec 31, 2020 | -1.34 Mn |